RT Journal Article
SR Electronic
A1 Alexander, Lori
T1 The SHIELD Trial: Final Results and Epidemiological and Public Policy Implications
JF MD Conference Express
YR 2011
FD SAGE Publications
VO 11
IS 8
SP 6
OP 7
DO 10.1177/155989771108001
UL http://mdc.sagepub.com/content/11/8/6.abstract
AB In patients with newly diagnosed type 2 diabetes mellitus (T2DM), complications are often present at the time of diagnosis, suggesting that clinical onset of the disease occurred years prior to diagnosis [Koopman RJ et al. Ann Fam Med 2006]. This article discusses the prevalence of metabolic risk among individuals with defined metabolic risk factors and T2DM and shared results from the Study to Help Improve Early evaluation and management of risk factors Leading to Diabetes [SHIELD] study.